Trial Profile
Measures of inflammation in low back pain (LBP) and anti-TNFα for the treatment of deemed discogenic LBP - an explorative study Measures of inflammation in low back pain (LBP) and anti-TNFα for the treatment of deemed discogenic LBP - an explorative study
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Back pain
- Focus Therapeutic Use
- 03 Nov 2016 Status changed from recruiting to discontinued.
- 07 Jul 2015 New trial record